Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,829 | 179 | 1,080 | 491 | -482 |
| Depreciation Amortization | 2,305 | 8,447 | 5,900 | 4,004 | 2,003 |
| Income taxes - deferred | -171 | 2,751 | -678 | -423 | -125 |
| Accounts receivable | 1,610 | -4,496 | 1,097 | -4,103 | -3,986 |
| Accounts payable and accrued liabilities | -921 | 446 | -9,151 | -6,073 | -414 |
| Other Working Capital | -5,471 | -12,358 | -8,451 | -9,127 | -10,592 |
| Other Operating Activity | 141 | 13,391 | 12,114 | 12,892 | 5,667 |
| Operating Cash Flow | $-7,336 | $8,360 | $1,911 | $-2,339 | $-7,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,787 | -3,062 | -4,743 | 1,356 | 5,675 |
| PPE Investments | -1,027 | -3,699 | -3,288 | -2,100 | -994 |
| Net Acquisitions | N/A | 4,307 | N/A | -588 | N/A |
| Purchase Sale Intangibles | N/A | -150 | -150 | -150 | -150 |
| Other Investing Activity | 16 | -175 | 4,170 | -137 | -141 |
| Investing Cash Flow | $-6,798 | $-2,629 | $-3,861 | $-1,469 | $4,540 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,755 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -3,925 | -3,925 | -3,925 | -3,925 |
| Other Financing Activity | 0 | -1,088 | -1,088 | -1,088 | 0 |
| Financing Cash Flow | $1,755 | $-5,013 | $-5,013 | $-5,013 | $-3,925 |
| Exchange Rate Effect | -4 | -292 | 895 | 547 | -222 |
| Beginning Cash Position | 56,756 | 56,330 | 56,330 | 56,330 | 56,330 |
| End Cash Position | 44,373 | 56,756 | 50,262 | 48,056 | 48,794 |
| Net Cash Flow | $-12,383 | $426 | $-6,068 | $-8,274 | $-7,536 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,336 | 8,360 | 1,911 | -2,339 | -7,929 |
| Capital Expenditure | -1,027 | -3,699 | -3,288 | -2,100 | -994 |
| Free Cash Flow | -8,363 | 4,661 | -1,377 | -4,439 | -8,923 |